Skip to content

US · OPTH · DRUG MANUFACTURERS - SPECIALTY & GENERIC

Optimi Health Corp. (OPTH) intrinsic value and stock valuation

$1.51as of 2026-11-21 · Mkt cap 16.26M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Optimi Health Corp. DCF and intrinsic value

InvestorsCraft values OPTH with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from OPTH’s statements →

Optimi Health Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Drug Manufacturers - Specialty & Generic Princeton, BC V0X 1W0 optimi.net

How the business is doing

Fiscal 2020–2025, USD

Revenue
$430K
20202025
Net income
-$-3.72M
20202025
Free cash flow
-$-2.72M
20202025
Total equity
$6.58M+4.5% 5y CAGRd
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2020–2025, USD
20252024202320222021
Revenue$430K$390K$180K$80K$0.00
Operating income-$-4.53M-$-5.61M-$-4.38M-$-6.63M-$-5.3M
Net income-$-3.72M-$-6.04M-$-5.19M-$-7.35M-$-6.02M
EPSd-$-1.16M-$-2.03M-$-1.79M-$-2.83M-$-2.58M
Operating cash flow-$-2.63M-$-4.28M-$-3.6M-$-4.58M-$-6.02M
Capital expenditure-$-90K-$-150K-$-800K-$-7.15M-$-4.94M
Free cash flow-$-2.72M-$-4.43M-$-4.41M-$-11.73M-$-10.96M
Total assets$15.2M$14.6M$16.5M$16.8M$23.5M
Total debt$6.69M$2.75M$1.71M$160K$250K
Net debt$5.55M$2.65M$360K-$-1.73M-$-8.18M
Total equity$6.58M$9.58M$13.2M$16M$21.1M
Cash and short-term investments$1.15M$100K$1.34M$1.89M$12.4M
Income statement
20252024202320222021
Revenue$430K$390K$180K$80K$0.00
Cost of revenue$2.5M$120K$340K$30K$50K
Gross profit-$-2.08M$270K-$-160K$50K-$-50K
Research and development expenses$350K$140K$150K$130K$240K
Selling, general and administrative expenses$2.72M$3.99M$3.93M$7.02M$5.06M
Other expenses-$-610K$1.74M$140K$290K$0.00
Operating expenses$2.46M$5.88M$4.22M$7.44M$5.3M
Cost and expenses$4.96M$6M$4.56M$6.72M$5.3M
Interest income$10K$0.00$140K$70K$60K
Interest expense$530K$430K$40K$30K$20K
Depreciation and amortization$950K$870K$730K$290K$0.00
Ebitda-$-2.23M-$-4.74M-$-4.42M-$-7.03M-$-5.35M
Operating income-$-4.53M-$-5.61M-$-4.38M-$-6.63M-$-5.3M
Total other income/expenses, net$820K-$-430K-$-810K-$-720K-$-720K
Income before tax-$-3.72M-$-6.04M-$-5.19M-$-7.35M-$-6.02M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-3.72M-$-6.04M-$-5.19M-$-7.35M-$-6.02M
Weighted average shares outstanding$3.2M$2.98M$2.9M$2.6M$2.33M
Weighted average diluted shares outstanding$3.2M$2.98M$2.9M$2.6M$2.33M
Balance sheet
20252024202320222021
Cash and short-term investments$1.15M$100K$1.34M$1.89M$12.4M
Net receivables$100K$120K$170K$100K$190K
Inventory$310K$890K$780K$260K$120K
Total current assets$1.83M$1.23M$2.43M$2.43M$14.3M
Property, plant and equipment, net$12.6M$13.3M$14.1M$14.4M$8.9M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$13.4M$13.3M$14.1M$14.4M$9.16M
Total assets$15.2M$14.6M$16.5M$16.8M$23.5M
Accounts payable$1.19M$750K$900K$560K$2.11M
Short-term debt$6.4M$990K$40K$90K$100K
Deferred revenue$210K$120K$110K-$-560K$0.00
Total current liabilities$8.5M$3.22M$1.61M$730K$2.24M
Long-term debt$320K$1.76M$1.67M$70K$160K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$160K$1.76M$1.67M$70K$160K
Capital lease obligations$180K$30K$70K$160K$250K
Total liabilities$8.65M$4.98M$3.28M$800K$2.4M
Common stock$31.7M$31.2M$28.7M$26.6M$25.2M
Retained earnings-$-27.28M-$-23.61M-$-17.65M-$-13.43M-$-6.19M
Accumulated other comprehensive income (loss)$2.12M$2.03M$2.16M$2.83M$2.1M
Total equity$6.58M$9.58M$13.2M$16M$21.1M
Total investments$10K$0.00$0.00$0.00$4M
Total debt$6.69M$2.75M$1.71M$160K$250K
Net debt$5.55M$2.65M$360K-$-1.73M-$-8.18M
Cash flow statement
20252024202320222021
Net income-$-3.71M-$-6.04M-$-5.19M-$-7.35M-$-6.02M
Depreciation and amortization$950K$870K$730K$290K$50K
Stock-based compensation$50K$60K$160K$1.01M$1.26M
Change in working capital$1.25M$760K$830K$1.33M-$-1.49M
Accounts receivable$30K$40K-$-70K$90K-$-100K
Inventory$500K$20K-$-210K-$-260K$0.00
Accounts payable-$-50K-$-130K$990K$0.00$260K
Net cash provided by operating activities-$-2.63M-$-4.28M-$-3.6M-$-4.58M-$-6.02M
Investments in property, plant and equipment-$-90K-$-150K-$-800K-$-7.15M-$-4.94M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-90K-$-150K-$-710K-$-3.15M-$-9.19M
Common stock issued$400K$2.04M$1.84M$1.3M$18.9M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$3.76M$3.19M$3.76M$1.19M$19.2M
Net change in cash$1.04M-$-1.24M-$-540K-$-6.54M$3.96M
Cash at end of period$1.15M$100K$1.34M$1.89M$8.43M
Operating cash flow-$-2.63M-$-4.28M-$-3.6M-$-4.58M-$-6.02M
Capital expenditure-$-90K-$-150K-$-800K-$-7.15M-$-4.94M
Free cash flow-$-2.72M-$-4.43M-$-4.41M-$-11.73M-$-10.96M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Optimi Health Corp.

        Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

        CEO
        Dane Stevens
        Employees
        6
        Beta
        1.59

        Explore

        Frequently asked questions

        What is the intrinsic value of Optimi Health Corp. (OPTH)?

        InvestorsCraft does not currently publish an intrinsic value for OPTH. How the IC value is calculated.

        Is OPTH undervalued?

        InvestorsCraft does not publish an undervaluation signal for OPTH at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.